Skip to Main Content

December 2022    Volume 3 Issue 12
Health Law Connections

Pfizer v. OIG, the Inflation Reduction Act, and the Future of Patient Assistance Programs

AHLA thanks the leaders of the Life Sciences Practice Group for contributing this feature article.
  • December 01, 2022
  • Jennifer Michael , Bass Berry & Sims PLC
Inflation Reduction Act

Cost-sharing is intended to encourage individuals to become better consumers of health care. The thinking goes that, by having some “skin in the game,” consumers will have a financial incentive to use services efficiently and choose lower-cost options when available. But cost-sharing also has a downside because deductibles, copayments, and other cost-sharing obligations that are too high may deter beneficiaries from obtaining the care they need.


You must be logged in to access this content.